戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  from the analysis of diffusion rates of the fluorescent antibody.
2 ules using sequential binding and elution of fluorescent antibodies.
3 interactions without the need for additional fluorescent antibodies.
4 into unfixed transplanted skin tissues using fluorescent antibodies.
5 ession under fluid shear after labeling with fluorescent antibodies.
6 proach that is based on chemically cleavable fluorescent antibodies.
7 6 nm in diameter, which, when labeled with a fluorescent antibody [2] or a latex bead [5], are seen t
8 ections of gingival tissue were stained with fluorescent antibodies against p24 antigen and different
9 n tissue that are then fixed, incubated with fluorescent antibodies against presynaptic proteins, and
10                                 Double-label fluorescent-antibody analysis with anti-IncA and an anti
11           Gene expression was confirmed with fluorescent antibodies and confocal microscopy.
12 -cell gene expression by staining cells with fluorescent antibodies and nucleic acids.
13 nt detection of single target molecules with fluorescent antibodies, and we show that these antibodie
14 ure assay (SVA), real-time PCR, and a direct fluorescent antibody assay (DFA) for rapid detection of
15 ne encephalitis (VEE) viruses by an indirect fluorescent antibody assay.
16 rlichiosis by comparing them to the indirect fluorescent-antibody assay "gold standard." The specific
17                                   The direct fluorescent-antibody assay (DFA) detected 132 (66.3%) po
18                     Cytospin-enhanced direct fluorescent-antibody assay (DFA) detected 49 (92.5%) and
19 RSV; Becton Dickinson, Sparks, MD), a direct fluorescent-antibody assay (DFA) for RSV (Bartels; Trini
20 sing 9 diagnostic kits were compared: direct fluorescent-antibody assay (DFA) kits (TechLab Giardia/C
21 ensitive than the traditional culture/direct fluorescent-antibody assay (DFA) method for detecting RS
22 re used to resolve the discrepancies: direct fluorescent-antibody assay (DFA) of sediment from a spun
23 performance and cost-effectiveness of direct fluorescent-antibody assay (DFA), commercial PCR, and li
24                       A comparison of direct fluorescent-antibody assay (DFA), culture, and two PCR a
25  responses of the 37 E. chaffeensis indirect fluorescent-antibody assay (IFA)-positive and 20 IFA-neg
26  further analyzed for Y. pestis infection by fluorescent-antibody assay and/or culture.
27 healthy humans were positive by the indirect fluorescent-antibody assay for all three antigens.
28 who were PCR positive but culture and direct fluorescent-antibody assay negative had clinical disease
29 d increase in sensitivity compared to direct fluorescent-antibody assay of seeded stool samples.
30 gative and CHL positive by a positive direct fluorescent-antibody assay or PCR test.
31                                     Indirect fluorescent-antibody assay procedures and virus neutrali
32 from cell culture supernatants and by direct fluorescent-antibody assay staining of the cell culture
33 r (77%) had E. chaffeensis-reactive indirect fluorescent-antibody assay titers of > or = 1:64; and th
34                                       Direct fluorescent-antibody assay was used to resolve discrepan
35 The evaluation was performed by the indirect fluorescent-antibody assay with Ehrlichia chaffeensis Ar
36  ELISA, ova and parasite test, and/or direct fluorescent-antibody assay.
37 nts that were negative by culture and direct fluorescent-antibody assay.
38 yme immunoassay (20%), culture (12%), direct fluorescent antibody assays (3%), and rapid tests (<1%).
39 thods, including rapid antigen tests, direct fluorescent antibody assays, and nucleic acid amplificat
40 hrlichiosis relies predominantly on indirect fluorescent-antibody assays and immunoblot analysis.
41 multi-color, single-molecule microscopy with fluorescent antibody-based probes that specifically bind
42 imers/microns2 as determined by quantitative fluorescent antibody binding.
43 ric labeling of proteins is achieved through fluorescent-antibody binding.
44            Permeability of F(ab)'2 secondary fluorescent antibody changes from 9.3 to 1.4 um(2) s(-1)
45 mproved labeling efficiency when detected by fluorescent antibodies compared to those collected from
46             Bacteria samples, treated with a fluorescent antibody complex specific to Streptococcus p
47                                          The fluorescent antibody conjugates show excellent tumor-tar
48 his behavior is in stark contrast to that of fluorescent antibody conjugates.
49                                     Finally, fluorescent antibodies demonstrate the presence of IRBP
50 ded Chlamydiazyme (Abbott), MicroTrak direct fluorescent antibody (DFA) (Syva), MicroTrak enzyme immu
51 tCycler PCR (LC-PCR) methods and by a direct fluorescent antibody (DFA) assay, which detects L. pneum
52                                       Direct-fluorescent antibody (DFA) detection remains the gold st
53 iratory symptoms were examined by the direct fluorescent antibody (DFA) technique.
54 f reverse transcription-PCR (RT-PCR), direct fluorescent antibody (DFA) test, and viral culture perfo
55 assays include enhanced cell culture, direct fluorescent antibody (DFA), messenger RNA (mRNA) detecti
56 test (RADT; pooled sensitivity, 64%), direct fluorescent antibody (DFA; 83%), and viral culture (86%)
57 with the performance of cell culture, direct fluorescent-antibody (DFA) assay (Syva MicroTrak; Syva C
58 obtained by testing 50 specimens by a direct fluorescent-antibody (DFA) assay.
59 red these methods to both culture and direct fluorescent-antibody (DFA) assays with microscopy for th
60 Lx system was tested in parallel with direct fluorescent-antibody (DFA) staining and rapid shell vial
61                      A combination of direct fluorescent-antibody (DFA) staining and virus culture wa
62 formed by a combination of reculture, direct fluorescent-antibody (DFA) staining of specimen sediment
63 r resolution of discrepant results by direct fluorescent-antibody (DFA) staining or PCR assay, the re
64 ed by both Amplicor PCR and Microtrak direct fluorescent-antibody (DFA) staining.
65 le expertise; enzyme immunoassays and direct fluorescent-antibody (DFA) stains have lowered hands-on
66 -flow immunoassay, with the MERIFLUOR direct fluorescent-antibody (DFA) test, the ProSpecT EZ micropl
67            With observed increases in direct fluorescent-antibody (DFA) testing volumes, we retrospec
68 elate the APTIMA assays with culture, direct fluorescent-antibody (DFA), and LCx CT and GC assays.
69 ere tested by both immunofluorescent (direct fluorescent-antibody [DFA]) staining and PCR.
70                                           By fluorescent antibody (FA) staining, persistent viruses V
71 iagnostics, Inc.]) and two commercial direct fluorescent-antibody (FA) assays for G. lamblia (Crypto/
72                                 Conventional fluorescent-antibody (FA) methods were compared to real-
73 d a method that used (a) immunostaining with fluorescent antibodies followed by confocal microscopy t
74 lular proteins of interest were labeled with fluorescent antibodies for fluorescence-activated cell s
75 g to membrane-bound TNF (mTNF), we created a fluorescent antibody for molecular mTNF imaging in this
76 ng using a dynamically binding, low-affinity fluorescent antibody fragment differentiates between spe
77 se data indicate that molecular imaging with fluorescent antibodies has the potential to predict ther
78                                 The indirect fluorescent antibody (IFA) assay is the diagnostic test
79  with E. chaffeensis as detected by indirect fluorescent antibody (IFA) assay.
80 ins, respectively, as determined by indirect fluorescent antibody (IFA) staining methods.
81 les cross-reacted with a whole-cell indirect fluorescent antibody (IFA) test and two multiantigen tes
82 cted of having HGE were examined by indirect fluorescent antibody (IFA) testing with the HGE agent no
83                         Twenty-nine indirect fluorescent antibody (IFA)-positive dog plasma specimens
84                               A new indirect fluorescent-antibody (IFA) assay with antigen produced i
85                                     Indirect fluorescent-antibody (IFA) staining methods with Ehrlich
86  specimens from 176 patients by the indirect fluorescent-antibody (IFA) technique with Ehrlichia equi
87 R and cell culture with that of the indirect fluorescent-antibody (IFA) test for the diagnosis of Pot
88 nosis has traditionally been by the indirect fluorescent-antibody (IFA) test.
89                                     Indirect fluorescent-antibody (IFA) testing on cerebrospinal flui
90      Sera from 20 HGE patients with indirect fluorescent-antibody (IFA) titers ranging from 1:20 to 1
91                Flow cytometry analysis after fluorescent antibody labeling revealed strong correlatio
92 show here that, in rat ventricular myocytes, fluorescent antibodies map the NBC isoforms NBCe1 and NB
93  in cycling NIH3T3 cells, using quantitative fluorescent antibody measurements of individual cells.
94 oped serum VZV antibodies as demonstrated by fluorescent antibody membrane antigen.
95  and results were in agreement with indirect fluorescent antibody methods for 86% of samples analyzed
96 orferi JMNT and N40 was analyzed by indirect fluorescent-antibody microscopy, polyacrylamide gel elec
97 , the primary colicin receptor, complexed to fluorescent antibody or colicin, is 0.05+/-0.01 mum2/s a
98 arget protein for immunoassay detection with fluorescent antibody probes.
99 chnique can be multiplexed and combined with fluorescent antibody protein staining to address a varie
100 using a small bioluminescent peptide tag and fluorescent antibodies, providing sensitive quantitation
101 nd Fusarium species, we developed polyclonal fluorescent-antibody reagents to Aspergillus fumigatus a
102 th Kir6.2 or Kir6.2deltaC37 and labeled with fluorescent antibodies revealed unique honeycomb pattern
103 l antibody specificity was demonstrated with fluorescent antibody sorting of cells engineered to expr
104                                              Fluorescent antibodies specific for CD11b, CD11c, CD80,
105 ergoing clinical testing for PCP with direct fluorescent antibody stain (DFA), respiratory PCR, and/o
106                                              Fluorescent antibody staining and image analysis were us
107 fects of treatment on entry were measured by fluorescent antibody staining of cells or by antigen cap
108  for LCR and culture were resolved by direct fluorescent antibody staining of culture sediments, two
109 e of large-scale serotyping studies in which fluorescent antibody staining of infected cells was used
110                                              Fluorescent antibody staining of the corresponding midgu
111 7 (26%) had laboratory evidence (by indirect fluorescent antibody staining or polymerase chain reacti
112                                              Fluorescent antibody staining revealed PCho(+) variants
113 lture transport medium with chlamydia direct fluorescent antibody staining were used to adjudicate ch
114                                           By fluorescent antibody staining with anti-p40 and -p35, th
115 , when rapid diagnosis could be made only by fluorescent antibody staining, a demanding technique ava
116 urface phenotype was monitored by monoclonal fluorescent antibody staining, and cytokine levels were
117 romosome-specific probes in conjunction with fluorescent antibody staining, we found that such stem c
118 r the presence of B. burgdorferi by indirect fluorescent antibody staining.
119  were compared with those obtained by direct fluorescent-antibody staining (DFA) and real-time PCR wi
120                                              Fluorescent-antibody staining and image analysis were us
121 ow RSV (BN) were compared to those of direct fluorescent-antibody staining and/or tissue culture for
122 T-positive specimens were resolved by direct fluorescent-antibody staining of sedimented culture tran
123 onventional virologic testing, consisting of fluorescent-antibody staining plus testing with the R-mi
124 odified trichrome blue stain and by indirect fluorescent-antibody staining with murine polyclonal ant
125  columnar epithelial cell adequacy by direct fluorescent-antibody staining.
126 entification as well as by cell culture with fluorescent-antibody staining.
127                                              Fluorescent-antibody studies were carried out with a spe
128 ibility of detecting HGG using near-infrared fluorescent antibody targeting EGFR.
129 amples that had been characterized by direct fluorescent antibody test (DFA) and DNA sequencing analy
130 ere evaluated for CDV antigen using a direct fluorescent antibody test (FAT).
131 cific 16S rRNA gene fragments by an indirect fluorescent antibody test and a nested PCR assay, respec
132 years and had negative results by the direct fluorescent antibody test for respiratory syncytial viru
133  of bovine coronavirus (BCV), on an indirect fluorescent antibody test.
134 es, and infected erythrocytes in an indirect fluorescent antibody test.
135 omparison of the sensitivity of the standard fluorescent-antibody test (FAT) for rabies antigen and t
136 e specimens that tested positive in a direct fluorescent-antibody test or in a confirmatory PCR test
137 he qRT-PCR assay to the gold standard direct fluorescent-antibody test.
138 Results for Bordetella culture and/or direct fluorescent antibody testing and a second LightCycler PC
139    Samples were tested by culture and direct fluorescent antibody testing for respiratory syncytial v
140  fixed cells or cell lysates was revealed by fluorescent antibody testing or enzyme-linked immunosorb
141                 Patients who had only direct fluorescent antibody testing performed or concurrent vir
142 oscopy, 60 (42.9%) by culture, 63 (45.0%) by fluorescent antibody testing, and 61 (43.6%) by real-tim
143 ing the other DNA amplification test, direct fluorescent antibody testing, and a DNA amplification te
144 body specific to B. burgdorferi, by indirect fluorescent antibody testing.
145  compared the performance of culture, direct fluorescent-antibody testing (DFA), and an in-house-deve
146                                       Direct fluorescent-antibody testing has a specificity of 99.6%
147 children were tested for influenza by direct fluorescent-antibody testing with PCR confirmation.
148 d recognize diagnostic limitations of direct fluorescent-antibody testing, which missed one-third of
149 m infected animals did not react in indirect fluorescent-antibody tests with Babesia microti antigen,
150 proteins, HLA class I molecules labeled with fluorescent antibody; the patchiness of the HLA class I
151                                              Fluorescent antibodies to ciliary proteins are used to v
152                 Monolayers were stained with fluorescent antibodies to detect total and dephosphoryla
153            Dissociated neurons identified by fluorescent antibodies to PLAP showed firing properties
154 cryosectioned, indirectly immunolabeled with fluorescent antibodies to sarcolemmal and myofibrillar m
155 ent with increasing nocodazole doses using a fluorescent antibody to alpha-tubulin.
156  previously validated sensitive and specific fluorescent antibody to membrane antigen (FAMA) assay.
157                                              Fluorescent antibody to membrane antigen (FAMA) assays a
158  and coincidence of 97.61% compared with the fluorescent-antibody-to-membrane-antigen (FAMA) test.
159 demonstrated to neutralize rabies virus in a fluorescent antibody virus neutralization assay, and con
160 Cas9-modified cell lines in combination with fluorescent antibodies, we developed a HiBiT-BRET immuno
161 ted for use with our recently reported "blue-fluorescent antibodies" with the aim of probing native a

 
Page Top